FILTER
LATEST INTERVIEWS
Akshay Charegaonkar
DIRECTOR, ANCHROM ENTERPRISES
Anchrom Enterprises offers high-end analytical solutions together with technical expertise, acting as the exclusive distributors of Camag HPTLC.
Bhagyesh Shah
MANAGING DIRECTOR, UNISON PHARMACEUTICALS
Unison Pharmaceuticals Private Limited was established in 1981, with a vision of providing quality affordable medicines across India and is now ready to go global.
Nompumelelo (Mpumi) Zikalala
MANAGING DIRECTOR, DE BEERS GROUP MANAGED OPERATIONS
De Beers Group outlines its projects across Canada as well as the its sustainability initiatives.
David Kelley
PRESIDENT AND CEO, CHAKANA COPPER
Chakana Copper proves that juniors can still be successful describing the progress at its Soledad project in Peru.
Marcos De Marchi
CEO, ELEKEIROZ
Elekeiroz speaks to GBR about the market conditions for petrochemicals in Brazil and how reforms can help the industry.
David DeJean
SENIOR VICE PRESIDENT, SYSTECH INTERNATIONAL
Systech International is a technology leader in supply chain safety and brand protection.
Federico Veller
EXECUTIVE MANAGER CHEMICALS, YPF
YPF explains how the company has evolved to benefit from the development of Vaca Muerta.
Krishna Kanumuri
CEO, SAI LIFE SCIENCES
Sai Life Sciences delivers advanced discovery, contract development and manufacturing solutions through a broad suite of capabilities across the molecular lifecycle.
Pelin İșçener
MARKETING AND SALES DIRECTOR, ECZACIBAȘI MONROL NÜKLEER ÜRÜNLER
Eczacıbaşı Monrol specializes in producing agents for PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scans, which are critical for detecting cancer, cardiological diseases and brain disorders, among other serious diseases.
Danny Callow
COO, AFRICAN GOLD GROUP
African Gold Group explains its progress at its Kobada gold project in Mali as it advances towards production.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2024 - Digital Interactive
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
"Cautious optimism. These two words best describe the state of mind of life sciences executives as we enter the second half of 2024. "
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
